Table 2.
Outcome | VF-CA (n=254) | A-CA (n=286) | p-value |
---|---|---|---|
Good Neurologic Outcome | 102 (44) | 46 (18) | <0.0001 |
Hospital Survival | 146 (58) | 100 (35) | <0.0001 |
Post-ROSC Neurologic Injury | <0.0001 | ||
PCAC I | 94 (37) | 41 (14) | |
PCAC II/III | 68 (27) | 57 (20) | |
PCAC IV | 62 (24) | 138 (48) | |
Not typable | 30 (12) | 50 (17) | |
Post-ROSC Cardiac Injury | |||
LVEF evaluated | 206 (81) | 157 (55) | <0.0001 |
LVEF (median [IQR]), % | 20 [35 – 55] | 55 [45 – 60] | <0.0001 |
Troponin I evaluated | 245 (96) | 269 (94) | ns |
Peak troponin I (ng/ml; median/IQR) | 7.8 [0.8 – 57] | 0.3 [0.0 – 1.5] | <0.0001 |
Abbreviations: VF-CA, cardiac etiology cardiac arrest; A-CA, asphyxial etiology cardiac arrest; ROSC, return of spontaneous circulation; PCAC, Pittsburgh Cardiac Arrest Category; LVEF, left ventricular ejection fraction